首页> 外文期刊>Future medicinal chemistry >Recent progress on inhibitors of the type II transmembrane serine proteases, hepsin, matriptase and matriptase-2
【24h】

Recent progress on inhibitors of the type II transmembrane serine proteases, hepsin, matriptase and matriptase-2

机译:II型跨膜丝氨酸胺蛋白酶,肝素,基质磷酸酶和基质磷酸酶-2的抑制剂的最新进展

获取原文
获取原文并翻译 | 示例
           

摘要

Members of the type II transmembrane serine proteases (TTSP) family play a vital role in cell growth and development but many are also implicated in disease. Two of the well-studied TTSPs, matriptase and hepsin proteolytically process multiple protein substrates such as the inactive single-chain zymogens pro-HGF and pro-macrophage stimulating protein into the active heterodimeric forms, HGF and macrophage stimulating protein. These two proteases also have many other substrates which are associated with cancer and tumor progression. Another related TTSP, matriptase-2 is expressed in the liver and functions by regulating iron homoeostasis through the cleavage of hemojuvelin and thus is implicated in iron overload diseases. In the present review, we will discuss inhibitor design strategy and Structure activity relationships of TTSP inhibitors, which have been reported in the literature.
机译:II型跨膜丝氨酸蛋白酶(TTSP)家族的成员在细胞生长和发育中发挥着至关重要的作用,但许多人也涉及疾病。 良好研究的TTSP,Matriptase和Hepsin中的两种蛋白水解处理多种蛋白质底物,例如无活性单链酶Pro-HGF和促巨噬细胞刺激蛋白,进入活性异二聚体形式,HGF和巨噬细胞刺激蛋白。 这两种蛋白酶还具有许多与癌症和肿瘤进展相关的其他底物。 另一种相关的TTSP,Mattiptase-2在肝脏中表达,通过通过血管肾上腺素的裂解来调节铁同性化,因此涉及铁过载疾病。 在本综述中,我们将讨论在文献中报道的TTSP抑制剂的抑制剂设计策略和结构活性关系。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号